The C2 subtype shows a high expression level of tumor growth pathways as well as immune-related pathways, and the expressions of immune checkpoint genes such as PD-1, PD-L1, and cytotoxic T lymphocyte-associated antigen (CTLA)4 are also higher than other subtypes (Figures 4H–J). The gene discussed is CD274; the disease is neoplasm.